Skip to main content
. 2021 Feb 24;12(2):211. doi: 10.1038/s41419-021-03493-2

Fig. 7. TRAF3 Lys138 mutants reduce the injury of BRL-3A cells with H/R.

Fig. 7

BRL-3A cells transfected with TRAF3 Lys138 mutants (K138R) plasmids or the corresponding WT and vector plasmids as indicated, and the cells were cultured under normal or H/R conditions. The following analysises were performed. AC ALT, AST, and LDH activities in the culture medium. Pretreated BRL-3A cells were incubated under normal or H/R conditions. Data are mean ± SD, n.s., not significant; **P < 0.01 by two-way ANOVA followed by Tukey’s test. n = 3 per group. D CCK-8 assay was used to examine cell survival. Data are mean ± SD, n.s., not significant; **P < 0.01 by two-way ANOVA followed by Tukey’s test. n = 6 per group. E ROS in BRL-3A cells. ROS staining was performed to evaluate the level of ROS in BRL-3A cells, and the stained fluorescence was observed using a fluorescence microscope. The cellular morphology and structure of BRL-3A cells by bright image investigation. FJ Proteins levels of p-IKKβ, IKKβ, p-IκBα, IκBα, p-p65, p65 in BRL-3A cells were evaluated using western blot (F) and quantified using a Gel-Pro Analyzer (GJ). Data are mean ± SD, n.s., not significant; **P < 0.01 by two-way ANOVA followed by Tukey’s test. n = 3 per group.